Last Updated: July 27, 2026

Drug Price Trends for NDC 00469-2602

✉ Email this page to a colleague

« Back to Dashboard

Average Pharmacy Cost for 00469-2602

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
MYRBETRIQ ER 50 MG TABLET	00469-2602-30	14.69177	EACH	2026-07-22
MYRBETRIQ ER 50 MG TABLET	00469-2602-90	14.69177	EACH	2026-07-22
MYRBETRIQ ER 50 MG TABLET	00469-2602-30	14.69406	EACH	2026-06-17
MYRBETRIQ ER 50 MG TABLET	00469-2602-90	14.69406	EACH	2026-06-17
MYRBETRIQ ER 50 MG TABLET	00469-2602-30	14.69405	EACH	2026-05-20
MYRBETRIQ ER 50 MG TABLET	00469-2602-90	14.69405	EACH	2026-05-20
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 00469-2602

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
MYRBETRIQ 50MG TAB,EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-30	30	240.20	8.00667	2021-09-30 - 2026-09-29	FSS
MYRBETRIQ 50MG TAB,EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-30	30	253.15	8.43833	2022-01-01 - 2026-09-29	FSS
MYRBETRIQ 50MG TAB,EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-30	30	273.90	9.13000	2023-01-01 - 2026-09-29	FSS
MYRBETRIQ 50MG TAB,EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-30	30	314.40	10.48000	2024-01-01 - 2026-09-29	FSS
MYRBETRIQ 50MG TAB,EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-30	30	320.42	10.68067	2024-02-15 - 2026-09-29	FSS
MYRBETRIQ 50MG TAB, EXTENDED RELEASE	Astellas Pharma U.S., Inc.	00469-2602-90	90	718.03	7.97811	2021-09-30 - 2026-09-29	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.